Related Experiment Videos
Usefulness of myoglobin radioimmunoassay determintion in CCU
Insights
Myoglobin radioimmunoassay is the earliest marker for acute myocardial infarction (M.I.), detecting micro-necroses missed by conventional tests. This early M.I. diagnosis aids in assessing necrosis extent and guiding treatment.
Area of Science:
- Cardiology
- Biochemistry
- Diagnostic Medicine
Background:
- Acute coronary events require early and accurate diagnosis.
- Conventional biomarkers for myocardial infarction (M.I.) have limitations in detecting early or subtle myocardial damage.
- Myoglobin's role as an early diagnostic marker needs further elucidation.
Purpose of the Study:
- To evaluate the utility of myoglobin radioimmunoassay for early diagnosis of acute myocardial infarction (M.I.).
- To assess myoglobin's ability to detect myocardial micronecroses not identified by standard methods.
- To correlate myoglobin levels with the extent of myocardial necrosis and clinical outcomes.
Main Methods:
- Myoglobin radioimmunoassay was performed on 112 patients admitted with acute coronary events at 0, 12, and 24 hours.
- Patients were categorized based on clinical, biological, and ECG criteria, including acute myocardial infarction (M.I.) subtypes.
- Myoglobin levels were compared between patients with confirmed M.I., suspected M.I. with micro-necroses, and non-cardiac controls.
Main Results:
- Significantly elevated myoglobin levels were observed in 77 patients with acute myocardial infarction (M.I.), appearing 3-4 hours after chest pain onset.
- Myoglobin detected micro-necroses in 12 of 23 cases initially diagnosed as acute coronary insufficiency, which were missed by conventional markers (SGOT, CPK, LDH).
- High myoglobin values (>800 ng/ml) correlated with left heart failure symptoms (65% of cases), with the highest levels in extensive anterior M.I. and pulmonary edema. Intramuscular antibiotic injections did not affect myoglobin levels.
Conclusions:
- Myoglobin radioimmunoassay is a valuable tool for the early diagnosis of acute myocardial infarction (M.I.).
- It effectively identifies myocardial micronecroses, offering prognostic and therapeutic insights beyond conventional diagnostic methods.
- Myoglobin assessment provides a reliable indication of the extent of myocardial necrosis.
Abstract:
In 112 patients with an acute coronary event, admitted to the CCU of Assaf-Harofeh Hospital, myoglobin radioimmunoassay was determined at 0 (time of admission), 12 and 24 hours. In 77 patients with acute myocardial infarction (M.I.) (64 patients with acute transmural and 13 with acute subendocardial M.I.), the myoglobin values were significantly increased. Appearing in blood 3-4 hours after the onset of chest pains, myoglobin represents the earliest marker of acute M.I. known until know. In 12 of 23 cases diagnosed at first as acute coronary insufficiency according to clinical, biological and E.C.G. criteria, significantly increased values of myoglobin were found, as an expression of micro-necroses which were not detected by conventional methods (SGOT, CPK, LDH). This finding has important practical, prognostic and therapeutical implications, showing that myoglobin radioimmunoassay may detect myocardial micronecroses which are not discovered by usual methods. Myoglobin radioimmunoassay assessment offers a valuable indication of necrosis extent. Values above 800 ng/ml were accompanied in 65% of our cases with symptoms and signs of left heart failure, the highest values of myoglobin being found in extensive anterior M.I. associated with acute pulmonary edema. In 9 non cardiac patients with repeated intra-muscular injections with antibotics, the myoglobin was at the upper normal limit, demonstrating that intra-muscular injections, at least with antibiotics, have no influence on myoglobin values. From our experience it appears that the myoglobin radioimmunoassay determination is a useful tool for the early establishment of M.I. diagnosis and the assessment of myocardial necrosis extent.